JP2004537500A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004537500A5 JP2004537500A5 JP2002555834A JP2002555834A JP2004537500A5 JP 2004537500 A5 JP2004537500 A5 JP 2004537500A5 JP 2002555834 A JP2002555834 A JP 2002555834A JP 2002555834 A JP2002555834 A JP 2002555834A JP 2004537500 A5 JP2004537500 A5 JP 2004537500A5
- Authority
- JP
- Japan
- Prior art keywords
- inhibitor
- patient
- nature
- body weight
- per
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69360000A | 2000-10-20 | 2000-10-20 | |
| US31818501P | 2001-09-07 | 2001-09-07 | |
| PCT/US2001/051339 WO2002055100A2 (en) | 2000-10-20 | 2001-10-22 | Method and composition for inhibition of tumor growth and enhancing an immune response |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008262301A Division JP2009046512A (ja) | 2000-10-20 | 2008-10-08 | 腫瘍の増殖の阻害および免疫応答の増強のための方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004537500A JP2004537500A (ja) | 2004-12-16 |
| JP2004537500A5 true JP2004537500A5 (https=) | 2005-04-21 |
Family
ID=26981351
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002555834A Pending JP2004537500A (ja) | 2000-10-20 | 2001-10-22 | 腫瘍の増殖の阻害および免疫応答の増強のための方法および組成物 |
| JP2008262301A Pending JP2009046512A (ja) | 2000-10-20 | 2008-10-08 | 腫瘍の増殖の阻害および免疫応答の増強のための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008262301A Pending JP2009046512A (ja) | 2000-10-20 | 2008-10-08 | 腫瘍の増殖の阻害および免疫応答の増強のための方法および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| EP (2) | EP1333850B1 (https=) |
| JP (2) | JP2004537500A (https=) |
| AT (1) | ATE405282T1 (https=) |
| AU (1) | AU2002243443A1 (https=) |
| DE (1) | DE60135481D1 (https=) |
| DK (1) | DK1333850T3 (https=) |
| ES (1) | ES2311558T3 (https=) |
| WO (1) | WO2002055100A2 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050069546A1 (en) * | 2003-09-30 | 2005-03-31 | Yaron Ilan | Educated NKT cells and their uses in the treatment of immune-related disorders |
| PL3718564T3 (pl) * | 2003-12-23 | 2024-03-18 | Genentech, Inc. | Nowe przeciwciała anty-IL 13 i ich zastosowania |
| US20050266005A1 (en) * | 2004-02-27 | 2005-12-01 | Heavner George A | Methods and compositions for treating IL-3 related pathologies |
| AR049390A1 (es) | 2004-06-09 | 2006-07-26 | Wyeth Corp | Anticuerpos contra la interleuquina-13 humana y usos de los mismos |
| US7501121B2 (en) | 2004-06-17 | 2009-03-10 | Wyeth | IL-13 binding agents |
| EP1824886B1 (en) | 2004-11-17 | 2010-12-22 | Amgen Inc. | Fully human monoclonal antibodies to il-13 |
| ES2523172T3 (es) * | 2005-02-04 | 2014-11-21 | Survac Aps | Vacuna de péptido de survivina |
| JP2010502224A (ja) | 2006-09-08 | 2010-01-28 | アボット・ラボラトリーズ | インターロイキン１３結合タンパク質 |
| WO2011003138A1 (en) * | 2009-07-06 | 2011-01-13 | The Australian National University | Immunomodulating compositions comprising interleukin 13 inhibitors and uses therefor |
| RU2578468C2 (ru) | 2010-12-16 | 2016-03-27 | Дженентек, Инк. | Способы диагностики и лечения, связанные с ингибированием th2 |
| US8492386B2 (en) | 2011-10-21 | 2013-07-23 | Abbvie Inc. | Methods for treating HCV |
| EP2583677A3 (en) | 2011-10-21 | 2013-07-03 | Abbvie Inc. | Methods for treating HCV comprising at least two direct acting antiviral agent, ribavirin but not interferon. |
| US8466159B2 (en) | 2011-10-21 | 2013-06-18 | Abbvie Inc. | Methods for treating HCV |
| DE202012012955U1 (de) | 2011-10-21 | 2014-07-14 | Abbvie Inc. | Eine Kombination aus mindestens zwei direkt wirkenden antiviralen Wirkstoffen (DAAs) für die Verwendung zur Behandlung von HCV |
| CN120904322A (zh) | 2013-09-13 | 2025-11-07 | 豪夫迈·罗氏有限公司 | 包含纯化的重组多肽的方法和组合物 |
| RU2016107435A (ru) | 2013-09-13 | 2017-10-18 | Дженентек, Инк. | Композиции и способы обнаружения и количественного определения белка клеток-хозяев в клеточных линиях и рекомбинантные полипептидные продукты |
| WO2015125652A1 (ja) * | 2014-02-21 | 2015-08-27 | Ｉｄａｃセラノスティクス株式会社 | 固形がんの治療剤 |
| EA201892448A1 (ru) | 2016-04-28 | 2019-06-28 | Эмори Юниверсити | Алкинсодержащие нуклеотидные и нуклеозидные терапевтические композиции и связанные с ними способы применения |
| TW202509218A (zh) * | 2023-07-12 | 2025-03-01 | 亨利傑克森軍方醫學基金會 | 用於抑制自然殺手細胞之組合物及方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6294322B1 (en) | 1988-01-26 | 2001-09-25 | The United States Of America As Represented By The Department Of Health And Human Services | Multideterminant peptides that elicit helper T-lymphocyte cytotoxic T-lymphocyte and neutralizing antibody responses against HIV-1 |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| WO1994004680A1 (en) * | 1992-08-21 | 1994-03-03 | Schering Corporation | Human interleukin-13 |
| US20010053371A1 (en) * | 1999-01-07 | 2001-12-20 | Waldemar Debinski | Method for diagnosing, imaging, and treating tumors using restrictive receptor for interleukin 13 |
| JPH09150569A (ja) | 1995-11-29 | 1997-06-10 | Riso Kagaku Corp | 色画像形成用シート |
| GB9625899D0 (en) * | 1996-12-13 | 1997-01-29 | Glaxo Group Ltd | Substances and their uses |
| US6013258A (en) | 1997-10-09 | 2000-01-11 | Zycos Inc. | Immunogenic peptides from the HPV E7 protein |
| MXPA01006006A (es) * | 1998-12-14 | 2004-08-12 | Genetics Inst | Cadena receptora de citocina. |
| MXPA01008142A (es) * | 1999-02-10 | 2003-07-21 | Welfide Corp | Compuestos de amida, y uso medicinal de los mismos. |
| US6703360B2 (en) * | 2000-04-07 | 2004-03-09 | Heska Corporation | Compositions and methods related to canine IgG and canine IL-13 receptors |
-
2001
- 2001-10-22 EP EP01989341A patent/EP1333850B1/en not_active Revoked
- 2001-10-22 JP JP2002555834A patent/JP2004537500A/ja active Pending
- 2001-10-22 DE DE60135481T patent/DE60135481D1/de not_active Expired - Lifetime
- 2001-10-22 ES ES01989341T patent/ES2311558T3/es not_active Expired - Lifetime
- 2001-10-22 AT AT01989341T patent/ATE405282T1/de not_active IP Right Cessation
- 2001-10-22 AU AU2002243443A patent/AU2002243443A1/en not_active Abandoned
- 2001-10-22 DK DK01989341T patent/DK1333850T3/da active
- 2001-10-22 EP EP08105062A patent/EP2027867A1/en not_active Withdrawn
- 2001-10-22 WO PCT/US2001/051339 patent/WO2002055100A2/en not_active Ceased
-
2008
- 2008-10-08 JP JP2008262301A patent/JP2009046512A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004537500A5 (https=) | ||
| NZ592039A (en) | Combination therapy for the treatment of ocular neovascular disorders | |
| NZ527113A (en) | Rapid-onset medicament for the treatment of sexual dysfunction | |
| WO2000064441A3 (en) | Compound for use as a medicament for treatment of disorders involving bronchocontraction | |
| WO2002041883A3 (en) | As-needed administration of tricyclic and other non-sri antidepressant drugs to treat premature ejaculation | |
| JP2002522485A5 (https=) | ||
| JP2002528502A5 (https=) | ||
| WO2004039325A3 (en) | Treatment of pain with jnk inhibitors | |
| JP2001510795A5 (https=) | ||
| JP2002524415A5 (https=) | ||
| RU2004135563A (ru) | Лекарственное средство для лечения повышенной активности мочевого пузыря | |
| WO2006029036A3 (en) | Combination therapy with glatiramer acetate and n-acetylcysteine for the treatment of multiple sclerosis | |
| WO2001068125A3 (en) | Methods and compositions for the treatment and prevention of erectile dysfunction | |
| WO2004093881A3 (en) | Use of dipyridamole or mopidamole for treatment and prevention of thrombo-embolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of thrombin receptors | |
| WO2005011579A3 (en) | Treatment of dependence withdrawal | |
| WO2002034267A8 (de) | Kombination eines transdermalen therapeutischen systems und einer oralen und/oder parenteralen zubereitung enthaltend dopaminagonisten zur behandlung dopaminerger erkrankungen | |
| JP2003504332A5 (https=) | ||
| CA2433833A1 (en) | Use of flumazenil in developing a drug for the treatment of alcohol dependence | |
| WO2004050025A3 (en) | Combination of ibuprofen and oxycodone for acute pain relief | |
| JP2002523437A5 (https=) | ||
| CA2313270A1 (en) | Use of deferiprone in treating and preventing iron-induced cardiac disease | |
| WO2005094899A8 (en) | Clusterin antisense therapy for treatment of cancer | |
| JP2003528919A5 (https=) | ||
| IL194500A0 (en) | Peptide substance enhancing capillaries resistance, pharmaceutical composition on its base and method of its application | |
| WO2001045715A3 (en) | Combinations of an adenosine a1 agonist with an opioid and their use in the treatment of pain |